Journal
CARBOHYDRATE POLYMERS
Volume 82, Issue 3, Pages 680-686Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.carbpol.2010.05.030
Keywords
Astragalus polysaccharide; Oral administration; FMDV; Adjuvant
Categories
Funding
- National Eleven-five Technological Supported Plan of China [2008BADB4B01, 2008BADB4B07, 2006BAD31B05-2]
- Scientific Research Foundation of Graduate School of China Agriculture University
Ask authors/readers for more resources
This study was conducted to evaluate the effects of astragalus polysaccharide (APS) on the immune responses of mice immunized with foot-and-mouth disease virus (FMDV) vaccine. BALB/c mice were randomly divided into five groups and 1 day before being immunized with FMDV vaccine, each group was orally administered APS at doses of 0, 0.125, 0.25, 0.5 and 1 mg, respectively. The cellular and humoral responses, including phagocytic capacity of peritoneal macrophage, the maturation of dendritic cells (DCs), splenic lymphocyte proliferation, cytokine production and antibody variation, were evaluated by a series of experiments after vaccination. The data showed that oral administration of APS significantly enhanced the phagocytic capacity of peritoneal macrophage, splenic lymphocyte proliferation, serum antibody titer, and the production of IL-4 and IL-10 in groups administered with 0.125-0.5 mg APS. The expression of CD40. CD86 and MHC-II on DCs was only slightly inhibited in mice given a low dose of APS, but was significantly enhanced in mice given higher doses. Furthermore, mice given the highest doses of APS showed markedly increased CD40 and MHC-II expression levels. These results suggest that orally administered APS could significantly enhance the efficacy of FMDV vaccination and has important implications for the further use of APS as a novel adjuvant. (C) 2010 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available